Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.

about

Comparison of Androgen Levels, Endocrine and Metabolic Indices, and Clinical Findings in Women with Polycystic Ovary Syndrome in Uygur and Han Ethnic Groups from Xinjiang Province in China

P2860

Q58697298-18560B8A-D790-446E-811A-EF78FBE3AEE0

P2860

Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.

Item

http://www.wikidata.org/entity/Q48303063

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Prevalence of dermatologic man ...... ovary syndrome in north China.

@en

Prevalence of dermatologic man ...... ovary syndrome in north China.

@nl

type

Item

label

Prevalence of dermatologic man ...... ovary syndrome in north China.

@en

Prevalence of dermatologic man ...... ovary syndrome in north China.

@nl

prefLabel

Prevalence of dermatologic man ...... ovary syndrome in north China.

@en

Prevalence of dermatologic man ...... ovary syndrome in north China.

@nl

P1476

Prevalence of dermatologic man ...... ovary syndrome in north China.

@en

P2093

Jin Xing

http://www.w3.org/2001/XMLSchema#string

Li-Ang Ma

http://www.w3.org/2001/XMLSchema#string

Rui-Feng Sun

http://www.w3.org/2001/XMLSchema#string

Wei Zhu

http://www.w3.org/2001/XMLSchema#string

Yan Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.

Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment.

P304

511-517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOCD.12387

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jin-Ge Feng

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28940857

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

biomarker

Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.

about

P2860

P2860

Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921